These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 14569206)

  • 41. [Current pathophysiological aspects of systemic sclerosis].
    Krieg T; Hunzelmann N
    Z Rheumatol; 2006 Jul; 65(4):275-8. PubMed ID: 16807741
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Circulating endothelial progenitor cells in systemic sclerosis: relation to impaired angiogenesis and cardiovascular manifestations.
    Nevskaya T; Bykovskaia S; Lyssuk E; Shakhov I; Zaprjagaeva M; Mach E; Ananieva L; Guseva N; Nassonov E
    Clin Exp Rheumatol; 2008; 26(3):421-9. PubMed ID: 18578963
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Modulation of endothelial dysfunction and apoptosis: UVA1-mediated skin improvement in systemic sclerosis.
    Breuckmann F; Stuecker M; Altmeyer P; Kreuter A
    Arch Dermatol Res; 2004 Oct; 296(5):235-9. PubMed ID: 15452726
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Rational therapy in the treatment of systemic sclerosis.
    Furst DE
    Curr Opin Rheumatol; 2000 Nov; 12(6):540-4. PubMed ID: 11092205
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Radical oxygen species production induced by advanced oxidation protein products predicts clinical evolution and response to treatment in systemic sclerosis.
    Servettaz A; Guilpain P; Goulvestre C; Chéreau C; Hercend C; Nicco C; Guillevin L; Weill B; Mouthon L; Batteux F
    Ann Rheum Dis; 2007 Sep; 66(9):1202-9. PubMed ID: 17363403
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Impairment of endothelial cell differentiation from bone marrow-derived mesenchymal stem cells: new insight into the pathogenesis of systemic sclerosis.
    Cipriani P; Guiducci S; Miniati I; Cinelli M; Urbani S; Marrelli A; Dolo V; Pavan A; Saccardi R; Tyndall A; Giacomelli R; Cerinic MM
    Arthritis Rheum; 2007 Jun; 56(6):1994-2004. PubMed ID: 17530639
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Nintedanib inhibits fibroblast activation and ameliorates fibrosis in preclinical models of systemic sclerosis.
    Huang J; Beyer C; Palumbo-Zerr K; Zhang Y; Ramming A; Distler A; Gelse K; Distler O; Schett G; Wollin L; Distler JH
    Ann Rheum Dis; 2016 May; 75(5):883-90. PubMed ID: 25858641
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Curcumin-induced apoptosis in scleroderma lung fibroblasts: role of protein kinase cepsilon.
    Tourkina E; Gooz P; Oates JC; Ludwicka-Bradley A; Silver RM; Hoffman S
    Am J Respir Cell Mol Biol; 2004 Jul; 31(1):28-35. PubMed ID: 14742295
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Predictors of the scleroderma phenotype in fibroblasts from systemic sclerosis patients.
    Qi Q; Guo Q; Tan G; Mao Y; Tang H; Zhou C; Zeng F
    J Eur Acad Dermatol Venereol; 2009 Feb; 23(2):160-8. PubMed ID: 19054252
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A possible contribution of lipocalin-2 to the development of dermal fibrosis, pulmonary vascular involvement and renal dysfunction in systemic sclerosis.
    Takahashi T; Asano Y; Noda S; Aozasa N; Akamata K; Taniguchi T; Ichimura Y; Toyama T; Sumida H; Kuwano Y; Tada Y; Sugaya M; Kadono T; Sato S
    Br J Dermatol; 2015 Sep; 173(3):681-9. PubMed ID: 25781362
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Systemic sclerosis and scleroderma circumscripta--disturbances of selected serum parameters which are responsible for vascular changes and CD34 expression in involved skin].
    Dziankowska-Bartkowiak B; Zebrowska A; Wagrowska-Danielewicz M; Kobos J; Waszczykowska E
    Przegl Lek; 2009; 66(12):1040-5. PubMed ID: 20514902
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Systemic Sclerosis Pathogenesis and Emerging Therapies, beyond the Fibroblast.
    Sierra-Sepúlveda A; Esquinca-González A; Benavides-Suárez SA; Sordo-Lima DE; Caballero-Islas AE; Cabral-Castañeda AR; Rodríguez-Reyna TS
    Biomed Res Int; 2019; 2019():4569826. PubMed ID: 30809542
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Control of fibrosis in systemic scleroderma.
    Mauch C; Eckes B; Hunzelmann N; Oono T; Kozlowska E; Krieg T
    J Invest Dermatol; 1993 Jan; 100(1):92S-96S. PubMed ID: 8423407
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Systemic Sclerosis Sera Impair Angiogenic Performance of Dermal Microvascular Endothelial Cells: Therapeutic Implications of Cyclophosphamide.
    Borghini A; Manetti M; Nacci F; Bellando-Randone S; Guiducci S; Matucci-Cerinic M; Ibba-Manneschi L; Weber E
    PLoS One; 2015; 10(6):e0130166. PubMed ID: 26076019
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Altered Dermal Fibroblasts in Systemic Sclerosis Display Podoplanin and CD90.
    Nazari B; Rice LM; Stifano G; Barron AM; Wang YM; Korndorf T; Lee J; Bhawan J; Lafyatis R; Browning JL
    Am J Pathol; 2016 Oct; 186(10):2650-64. PubMed ID: 27565038
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Th17 cells and IL-17 promote the skin and lung inflammation and fibrosis process in a bleomycin-induced murine model of systemic sclerosis.
    Lei L; Zhao C; Qin F; He ZY; Wang X; Zhong XN
    Clin Exp Rheumatol; 2016; 34 Suppl 100(5):14-22. PubMed ID: 26750756
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Systemic sclerosis sine scleroderma.
    Kucharz EJ; Kopeć-Mędrek M
    Adv Clin Exp Med; 2017 Aug; 26(5):875-880. PubMed ID: 29068586
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Decreased secretion of MMP by non-lesional late-stage scleroderma fibroblasts after selection via activation of the apoptotic Fas-pathway.
    Chabaud S; Corriveau MP; Grodzicky T; Senécal JL; Chartier S; Raymond Y; Moulin VJ
    J Cell Physiol; 2011 Jul; 226(7):1907-14. PubMed ID: 21506121
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Impaired growth response to endothelin-1 in scleroderma fibroblasts.
    Kikuchi K; Kadono T; Sato S; Tamaki K; Takehara K
    Biochem Biophys Res Commun; 1995 Feb; 207(2):829-38. PubMed ID: 7864878
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Does transformation of microvascular endothelial cells into myofibroblasts play a key role in the etiology and pathology of fibrotic disease?
    Karasek MA
    Med Hypotheses; 2007; 68(3):650-5. PubMed ID: 17045756
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.